PL BioScience Overview
- Year Founded
-
2015
- Status
-
Private
- Employees
-
28
- Latest Deal Type
-
Series B
- Investors
-
15
PL BioScience General Information
Description
Operator of a biotech platform designed to provide animal-component-free supplements for cell growth. The company offers human-derived and fully lab-made platelet lysate products, produced under rigorous standards to meet the growing demand for cell culture media for all phases of research and development with stem cells, enabling researchers and manufacturers in regenerative medicine, cell therapy, and biopharmaceutical development to access safer, ethically sourced, and scalable cell culture supplements.
Contact Information
Website
www.pl-bioscience.comCorporate Office
- Auf der Hüls 184-186
- 52068 Aachen
- Germany
Corporate Office
- Auf der Hüls 184-186
- 52068 Aachen
- Germany
PL BioScience Timeline
PL BioScience Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Later Stage VC (Series B) | Completed | Generating Revenue | ||||
| 6. Accelerator/Incubator | 25-Feb-2025 | Completed | Generating Revenue | |||
| 5. Later Stage VC (Series A) | 08-Aug-2024 | Completed | Generating Revenue | |||
| 4. Accelerator/Incubator | 01-Jan-2023 | Completed | Generating Revenue | |||
| 3. Later Stage VC (Series A) | 21-May-2021 | Completed | Generating Revenue | |||
| 2. Grant | 01-Jan-2020 | Completed | Generating Revenue | |||
| 1. University Spin-Out | 01-Jan-2015 | Completed | Generating Revenue |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
PL BioScience Patents
PL BioScience Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026234149-A1 | Artificial platelet lysate, methods for preparation and uses thereof | Pending | 07-May-2025 | ||
| EP-4276173-A1 | Stable human platelet lysate composition, methods and uses thereof | Inactive | 10-May-2022 | ||
| EP-4522196-A1 | Stable human platelet lysate composition, methods and uses thereof | Pending | 10-May-2022 | ||
| US-20250320456-A1 | Stable human platelet lysate composition, methods and uses thereof | Pending | 10-May-2022 | ||
| WO-2023218351-A1 | Stable human platelet lysate composition, methods and uses thereof | Inactive | 10-May-2022 | C12N5/0644 |
PL BioScience Signals
PL BioScience Investors (15)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Scale Up.NRW | Accelerator/Incubator | |||
| Avant Bio | Growth/Expansion | Minority | ||
| better ventures (Germany) | Angel Group | Minority | ||
| D11Z.Ventures | Venture Capital | Minority | ||
| Goodface Capital | Venture Capital | Minority |
PL BioScience FAQs
-
When was PL BioScience founded?
PL BioScience was founded in 2015.
-
Where is PL BioScience headquartered?
PL BioScience is headquartered in Aachen, Germany.
-
What is the size of PL BioScience?
PL BioScience has 28 total employees.
-
What industry is PL BioScience in?
PL BioScience’s primary industry is Biotechnology.
-
Is PL BioScience a private or public company?
PL BioScience is a Private company.
-
What is PL BioScience’s current revenue?
The current revenue for PL BioScience is .
-
How much funding has PL BioScience raised over time?
PL BioScience has raised $13M.
-
Who are PL BioScience’s investors?
Scale Up.NRW, Avant Bio, better ventures (Germany), D11Z.Ventures, and Goodface Capital are 5 of 15 investors who have invested in PL BioScience.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process